Otsuka Holdings
4578.T
#776
Rank
HK$249.19 B
Marketcap
HK$471.84
Share price
0.71%
Change (1 day)
17.70%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Earnings for Otsuka Holdings (4578.T)

Earnings in 2023: HK$8.20 Billion

According to Otsuka Holdings 's latest financial reports the company's current earnings are HK$14.47 Billion. In 2023 the company made an earning of HK$8.20 Billion a decrease over its 2022 earnings that were of HK$10.38 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Otsuka Holdings from 2010 to 2023

Annual earnings

Year Earnings Change
2023HK$8.20 B-20.93%
2022HK$10.38 B-12.7%
2021HK$11.89 B-19.92%
2020HK$14.85 B13.9%
2019HK$13.03 B52.07%
2018HK$8.57 B11.22%
2017HK$7.70 B-36.03%
2016HK$12.05 B31.15%
2015HK$9.18 B
2013HK$19.07 B33.52%
2012HK$14.28 B-4.65%
2011HK$14.98 B45.53%
2010HK$10.29 B